Lanean...
Potential SARS-CoV-2 main protease inhibitors
The coronavirus disease 2019 (COVID-19) pandemic has prompted an urgent need for new treatment strategies. No target-specific drugs are currently available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but new drug candidates targeting the viral replication cycle are being explor...
Gorde:
| Argitaratua izan da: | Drug Discov Today |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Ltd.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724992/ https://ncbi.nlm.nih.gov/pubmed/33309533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2020.12.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|